Pliant Therapeutics, Inc. (PLRX)
USD 14.0
(-2.57%)
USD 14.0
(-2.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.58 Million | 9.68 Million | 7.57 Million | 41.81 Million | 57.05 Million | - |
| Cost of Revenue | 1.84 Million | 3.68 Million | 3.2 Million | - | - | 666 Thousand |
| Gross Profit | -261 Thousand | 6 Million | 4.36 Million | 41.81 Million | 57.05 Million | -666 Thousand |
| Operating Expenses | 185.72 Million | 136.88 Million | 27.55 Million | 83.46 Million | 58.28 Million | 30.91 Million |
| Selling, General and Administrative Expenses | 57.92 Million | 39.94 Million | 27.55 Million | 17.26 Million | 10.93 Million | 6.5 Million |
| Research and Development Expenses | 127.79 Million | 96.93 Million | 77.54 Million | 66.19 Million | 47.35 Million | 24.41 Million |
| Other Expenses | - | - | -77.54 Million | -366 Thousand | -216 Thousand | -49 Thousand |
| Cost and Expenses | 185.72 Million | 136.88 Million | 27.55 Million | 83.46 Million | 58.28 Million | 30.91 Million |
| Operating Income | -184.14 Million | -127.2 Million | -19.98 Million | -41.64 Million | -1.23 Million | -30.91 Million |
| Interest Expense | 1.26 Million | 791 Thousand | 272 Thousand | 366 Thousand | 216 Thousand | - |
| Income Tax Expense | - | -1.82 Million | -1.8 Million | -1.78 Million | -816 Thousand | 639 Thousand |
| Earnings before Tax | -161.33 Million | -123.32 Million | -19.71 Million | -41.53 Million | -631 Thousand | -30.27 Million |
| Net Income | -161.33 Million | -121.49 Million | -17.9 Million | -39.74 Million | 185 Thousand | -30.27 Million |
| Earnings Per Share Basic | -2.75 | -2.89 | -0.50 | -1.12 | 0.01 | -1.83 |
| Earnings Per Share Diluted | -2.75 | -2.89 | -0.50 | -1.12 | 0.01 | -1.83 |
| Weighted Average Shares Outstanding | 58.71 Million | 42.01 Million | 35.84 Million | 35.55 Million | 35.55 Million | 16.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.71 Million | 42.01 Million | 35.84 Million | 35.55 Million | 35.55 Million | 16.51 Million |
| Gross Margin | -0.17 | 0.62 | 0.58 | 1.00 | 1.00 | - |
| EBIT Margin | -100.14 | -12.65 | -2.64 | -1.00 | -0.00 | - |
| Profit Margin | -102.11 | -12.54 | -2.36 | -0.95 | 0.00 | - |
| EBITDA | -158.22 Million | -118.84 Million | -95.72 Million | -40.33 Million | -118 Thousand | -30.24 Million |
| Earnings Before Tax Margin | -116.55 | -13.13 | -2.64 | -1.00 | -0.02 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.58 Million | 4.83 Million | - | 248 Thousand |
| Cost of Revenue | 622 Thousand | 513 Thousand | 1.84 Million | 464 Thousand | 1.04 Million | 1.1 Million |
| Gross Profit | -622 Thousand | -513 Thousand | -261 Thousand | 4.37 Million | -1.04 Million | -856 Thousand |
| Operating Expenses | 60.01 Million | 51.87 Million | 183.88 Million | 46.57 Million | 47.68 Million | 47.57 Million |
| Selling, General and Administrative Expenses | 15.02 Million | 15.24 Million | - | 13.85 Million | 15.34 Million | 14.57 Million |
| Research and Development Expenses | 44.99 Million | 36.63 Million | - | 32.71 Million | 32.33 Million | 33 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 60.63 Million | 52.39 Million | 185.72 Million | 47.03 Million | 47.68 Million | 47.57 Million |
| Operating Income | -60.63 Million | -52.39 Million | -184.14 Million | -47.03 Million | -47.68 Million | -47.32 Million |
| Interest Expense | 868 Thousand | 445 Thousand | 1.26 Million | 321 Thousand | 6.51 Million | 319 Thousand |
| Income Tax Expense | - | 469.72 Thousand | 1.67 Million | 3.39 Million | -448 Thousand | 6.45 Million |
| Earnings before Tax | -55.85 Million | -46.95 Million | -161.33 Million | -41.1 Million | -41.48 Million | -41.19 Million |
| Net Income | -55.85 Million | -46.95 Million | -161.33 Million | -41.1 Million | -41.48 Million | -41.19 Million |
| Earnings Per Share Basic | -0.92 | -0.78 | - | -0.69 | -0.70 | -0.70 |
| Earnings Per Share Diluted | -0.92 | -0.78 | - | -0.69 | -0.70 | -0.70 |
| Weighted Average Shares Outstanding | 60.38 Million | 60.18 Million | 58.71 Million | 59.9 Million | 59.68 Million | 59.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.38 Million | 60.18 Million | 58.71 Million | 59.9 Million | 59.68 Million | 59.17 Million |
| Gross Margin | - | - | -0.17 | 0.90 | - | -3.45 |
| EBIT Margin | - | - | - | -9.62 | - | -162.89 |
| Profit Margin | - | - | -102.11 | -8.49 | - | -166.10 |
| EBITDA | -60.01 Million | -51.87 Million | - | -46.57 Million | -47.68 Million | -40.39 Million |
| Earnings Before Tax Margin | - | - | -116.55 | -9.72 | - | -190.84 |
2929
BERY
0HGV
NICE
HLI
600438